TABLE 1.
Patient’s demographics and baseline clinical characteristics.
| Characteristics | Control group (n = 50) | Quercetin group (n = 50) | p-value |
|---|---|---|---|
| Gender, male, female (n) | 25, 25 | 23, 27 | n.s |
| Age, mean ± SD (years) | 54.1 ± 2.03 | 41.1 ± 2.03 | <0.001 |
| Comorbidities* (n) | |||
| None/single | 32 | 35 | n.s |
| Two or more | 18 | 15 | n.s |
| COVID-19 symptoms (n) | |||
| Fever^ | 43 | 41 | n.s |
| Cough | 29 | 28 | n.s |
| Myalgia | 28 | 29 | n.s |
| Sore throat | 24 | 23 | n.s |
| Dyspnoea | 12 | 9 | n.s |
| Headache | 1 | 3 | n.s |
| Flu-like symptoms | 5 | 6 | n.s |
| Weakness | 4 | 3 | n.s |
SD, standard deviation; n.s., not significant; *, hypertension; type 2 diabetes, heart disease, kidney disease, hypercholesterolemia, obesity, asthma/allergy; ^, no of cases with fever >39.5°C, average value for both groups was 38.7°C.